Mesenchymal stem cell therapy in neonates

Basit Öğe Kaydı
dc.contributor.authorAslan, Mustafa Törehan
dc.date.accessioned2024-10-29T17:43:49Z
dc.date.available2024-10-29T17:43:49Z
dc.date.issued2023
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractMesenchymal stem cells (MSC) therapy can overcome the damage caused by increased inflammation in cells and tissues that can occur due to many negative effects in newborns, increase their regeneration and perform various reparative functions (mainly with the paracrine effect), has been used in recent years to overcome very important morbidities and devastating problems [e.g., intraventricular hemorrhage (IVH), hypoxic-ischemic encephalopathy (HIE) and bronchopulmonary dysplasia (BPD)]. It has been suggested that the therapeutic effects of treatments with microvesicles and extracellular vesicles (EVs) containing exosomes, another secretory package of MSCs, which may be the other side of the coin and trending recently, may be better compared to MSCs. In the light of recent studies, stem cell therapy in neonatal diseases seems like a hope for the excitement of neonatologists. © 2023 Nova Science Publishers, Inc. All rights reserved.
dc.identifier.endpage473
dc.identifier.isbn979-888697714-1
dc.identifier.isbn979-888697545-1
dc.identifier.scopus2-s2.0-85159884891
dc.identifier.startpage465
dc.identifier.urihttps://hdl.handle.net/20.500.11776/12634
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherNova Science Publishers, Inc.
dc.relation.ispartofCurrent Topics in Perinatology and Neonatology
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBronchopulmonary dysplasia
dc.subjectHypoxic-ischemic encephalopathy
dc.subjectIntraventricular hemorrhage
dc.subjectMesenchymal stem cell therapy
dc.subjectNeonate
dc.subjectStem cell
dc.titleMesenchymal stem cell therapy in neonates
dc.typeBook Chapter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu